Magenta Therapeutics, Inc.

Home » Magenta Therapeutics, Inc.

IPO

Magenta Therapeutics, Inc.

We are a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients.

Symbol

MGTA

Price Range
$14.00 - $16.00

Final Shares
6,666,667

Anticipated Date
TBD

Underwriters
J.P. Morgan, Goldman Sachs & Co. LLC, Cowen, Wedbush PacGrow

To view the prospectus for Magenta Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253